Irene A Abela
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study.
Chammartin F, Darling K, Abela I, Battegay M, Furrer H, Calmy A, Bernasconi E, Schmid P, Hoffmann M, Bucher H, and the Swiss HIV Cohort Study. CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2022; 91:508.
Sep 23, 2022CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study.
Sep 23, 2022J Acquir Immune Defic Syndr 2022; 91:508
Chammartin Frédérique, Darling Katharine, Abela Irene A, Battegay Manuel, Furrer Hansjakob, Calmy Alexandra, Bernasconi Enos, Schmid Patrick, Hoffmann Matthias, Bucher Heiner C, and the Swiss HIV Cohort Study
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS).
Hachfeld A, Atkinson A, Stute P, Calmy A, Tarr P, Darling K, Babouee Flury B, Polli C, Sultan-Beyer L, Abela I, Aebi-Popp K, Swiss HIV Cohort Study (SHCS). Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS). HIV Med 2022; 23:417-425.
Feb 22, 2022Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS).
Feb 22, 2022HIV Med 2022; 23:417-425
Hachfeld Anna, Atkinson Andrew, Stute Petra, Calmy Alexandra, Tarr Philip E, Darling Katharine, Babouee Flury Baharak, Polli Christian, Sultan-Beyer Leila, Abela Irene A, Aebi-Popp Karoline, Swiss HIV Cohort Study (SHCS)
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.
Schmiedeberg K, Abela I, Pikor N, Vuilleumier N, Schwarzmueller M, Epp S, Pagano S, Grabherr S, Patterson A, Nussberger M, Trkola A, Ludewig B, von Kempis J, Rubbert-Roth A. Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA. RMD Open 2022; 8
Jan 1, 2022Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.
Jan 1, 2022RMD Open 2022; 8
Schmiedeberg Kristin, Abela Irene A, Pikor Natalia, Vuilleumier Nicolas, Schwarzmueller Magdalena, Epp Selina, Pagano Sabrina, Grabherr Sarah, Patterson Angelica Brooke, Nussberger Madalina, Trkola Alexandra, Ludewig Burkhard, von Kempis Johannes, Rubbert-Roth Andrea
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
Abela I, Günthard H, Bernasconi E, Cavassini M, Schmid P, Calmy A, Furrer H, Hirsch H, Perreau M, Klimkait T, Yerly S, Böni J, Scherrer A, Swiss HIV Cohort Study. Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients. Clin Infect Dis 2020; 70:297-303.
Jan 2, 2020Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
Jan 2, 2020Clin Infect Dis 2020; 70:297-303
Abela Irene A, Günthard Huldrych F, Bernasconi Enos, Cavassini Matthias, Schmid Patrick, Calmy Alexandra, Furrer Hansjakob, Hirsch Hans H, Perreau Matthieu, Klimkait Thomas, Yerly Sabine, Böni Jürg, Scherrer Alexandra U, Swiss HIV Cohort Study